期刊文献+

三基因突变小鼠血脂代谢及动脉粥样硬化早期病变特征 被引量:11

The characteristics of atherosclerotic early lesion in treble lipid metabolism genes mutant mouse
原文传递
导出
摘要 目的研究血脂代谢相关基因与瘦素受体基因联合突变导致小鼠血脂代谢紊乱的发生机制和动脉粥样硬化早期病变的特点及两者间的关系。方法应用生物化学及组织形态学手段对三基因突变(apoE-/-/LDLR-/-/Leprdb/db)与双基因突变(apoE-/-/LDLR-/-)小鼠和单基因突变(Leprdb/db)小鼠之间血脂及动脉粥样硬化早期病变的差异进行了比较研究。结果三基因突变小鼠3周龄时血浆总胆固醇、甘油三酯和血糖浓度分别为(1988±190)、(293±029)和(727±088)mmol/L,均高于双基因和单基因突变小鼠,同时出现轻微的主动脉内膜损伤,血脂及动脉粥样硬化程度随年龄增长而加重。11周龄三基因突变小鼠血浆总胆固醇、甘油三酯和血糖水平分别高出双基因突变小鼠166、141和24倍,且动脉内膜病变较双基因和单基因突变小鼠明显,其严重程度与血脂紊乱正相关。结论三个脂代谢相关基因联合突变在导致小鼠血脂代谢紊乱及主动脉粥样硬化病变的发生发展中起重要作用。 Objective To clarify the effects of polygenetic disfunction in lipid metabolism and atherogenesis in the mutant mice. Methods Treble lipid metabolic gene mutant (apoE -/- /LDLR -/- /Lepr db/db ) mice has been established and a comparative analysis was done with the mice of other lipid metabolism related gene mutants, including double gene mutant (apoE -/- /LDLR -/- ) and single gene mutants (apoE -/- , LDLR -/- and Lepr db/db ) mice, by using biochemical and pathological techniques. Results A various significant elevation in plasma level of total cholesterol (TC), triglyceride(TG) and glucose was found with progressing of time at 3 week old young treble gene mutant mice. They reached (19 88±1 90), (2 93±0 29)and (7 27±0 88)mmol/L, respectively, and higher than those in double and signal gene mutants . The apoE -/- /LDLR -/- /Lepr db/db mice was accompanied by endothelial edema, endothelial deciduation in local area at this age. In addition, other atherosclerotic lesions such as monocyte/macrophage infiltration and adhere/enter to subendothelium, foam cell formation, rupture of inner elastic lamina and intimal thickness by accumulation and proliferation of smooth muscle cells and extracellular matrix were found in local regions of aortic root and arch areas from 7 11week old treble gene mutants. The atherosclerotic lesions were progressing with age until the time point of investigation and related positively with the levels of TC and TG. Conclusion Treble lipid metabolic gene mutant (apoE -/- /LDLR -/- /Lepr db/db ) were highly contributed to hyperlipidemia and process of atherogenetic lesions in the young mutants. Our data indicated that lipid metabolism related polygenetic mutation was a more critical key risk factor than those of double and signal gene disfunction during atherogenesis development.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2004年第11期1009-1012,共4页 Chinese Journal of Cardiology
基金 浙江省自然科学基金课题(ZB0211)
  • 相关文献

参考文献14

  • 1Plump AS, Smith JD, Hayek T, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell, 1992, 71: 343-353.
  • 2Zhang SH, Reddick RL, Piedrahita JA ,et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science, 1992, 258: 468-471.
  • 3Ishibashi S, Herz J, Maeda N, et al. The two-receptor model of lipoprotein clearance: tests of the hypothesis in ''knockout'' mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci U S A, 1994, 91: 4431-4
  • 4Tartaglia LA. The leptin receptor. J Biol Chem, 1997, 272: 6093-6096.
  • 5Horvat S, Bunger L. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay for the mouse leptin receptor Lepr(db) mutation. Lab Anim, 1999, 33: 380-384.
  • 6Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993, 362: 801-809.
  • 7Linda KC. ApoE in atherosclerosis: a protein with multiple hats. Arterolscler Thromb Vasc Biol, 2000, 20: 1852-1853.
  • 8Swertfeger DK,Bu G,Hui DY. Low density lipoprotein receptor-related protein mediates apolipoprotein E inhibition of smooth muscle cell migration. J Biol Chem, 2002, 277: 4141-4146.
  • 9Ishibashi S, Goldstein JL, Brown MS, et al. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest, 1994, 93: 1885-1893.
  • 10Veniant MM,Withycombe S,Young SG. Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-)and Ldlr(-/-) mice. Arterioscler Thromb Vasc Biol, 2001, 21: 1567-1570.

共引文献1

同被引文献124

  • 1李金平,胡厚源.慢性应激与动脉粥样硬化[J].心血管病学进展,2009,30(6):1020-1022. 被引量:13
  • 2金晓蕾,孙文夏,施育平,郦佳慧,陈汉民,潘杰.脂代谢相关三基因突变小鼠肝组织基因表达差异研究[J].中华医学遗传学杂志,2005,22(1):27-30. 被引量:9
  • 3卢咏才,王淑华,刘小青,郭肇铮,甄二真,贾绪东,周玉琳.高脂血症、脂质过氧化、抗氧化酶活性与动脉粥样硬化的关系[J].中国病理生理杂志,1993,9(3):391-396. 被引量:50
  • 4Devlin CM, Lee S J, Kuriakose G, et al. An apolipoprotein (a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo. Arterioscler Thromb Vasc Biol, 2005, 25(8) : 1704-1710.
  • 5Joyce CW, Wagner EM, Basso F, et al. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogeniclipoproteins and enhanced atherosclerosis. J Biol Chem, 2006, 281 (44) : 33053-33065.
  • 6Reddy JK, Rao MS. Lipid metabolism and liver inflammation. Ⅱ. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol, 2006, 290 (5) :852-858.
  • 7Boadu E, Choi HY, Lee DW, et al. Correction of apolipoprotein A-I mediated lipid efflux and high density lipoprotein particle formation in human niemann-pick type C disease fibroblasts. J Biol Chem, 2006, 281 (48): 37081-37090.
  • 8Wang X,Paigen B. Genetics of variation in HDL cholesterol in humans and mice. Circ Res, 2005, 96( 1 ) : 27-42.
  • 9Watanabe Y, Jiang S, Takabe W, et al. Expression of the LXRalpha protein in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol, 2005, 25(3) : 622-627.
  • 10Levin N, Bischoff ED, Daige CL, et al. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler Thromb Vasc Biol, 2005, 25(1 ) : 135-142.

引证文献11

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部